title: 3 New Biologics To Be Worth $14B in Sales by 2019.
authors.forename: Katherine T
authors.initials: KT
authors.lastname: Adams
mesh_terms: D001688:Biological Products / Q000191:economics*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001688:Biological Products